#Peptide Microarray Market Size

[healthcare-updates-with-sns]

Peptide Microarray Market: Market Trends and Future Outlook 2024-2032

The global peptide microarray market is expected to witness significant growth in the coming years due to the increasing adoption of personalized medicine, advancements in biotechnology, and the rising need for efficient and high-throughput screening methods. Peptide microarrays are widely used for various applications, including biomarker discovery, drug development, disease diagnostics, and immunology research. These arrays enable researchers to study protein-peptide interactions, making them indispensable tools in molecular biology and biochemistry.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/4098

Market Segmentation

The peptide microarray market is segmented based on the following categories:

By Type:

Analytical Peptide Microarrays: These are primarily used in drug discovery, disease diagnostics, and proteomics research.

Functional Peptide Microarrays: Focused on studying peptide functions in relation to specific diseases and biological processes.

By Application:

Drug Discovery: Peptide microarrays are used to identify bioactive peptides for drug development.

Diagnostics: Utilized for identifying biomarkers and conducting diagnostic tests for various diseases.

Research and Development: Peptide microarrays support academic and clinical research in the fields of molecular biology, biochemistry, and immunology.

By End-User:

Pharmaceutical and Biotechnology Companies: Peptide microarrays help in drug discovery, biomarker identification, and disease management.

Academic and Research Institutes: These institutions use peptide microarrays for scientific studies and experimental applications.

By Region:

North America: Dominates the peptide microarray market due to the presence of advanced research facilities and a strong healthcare infrastructure.

Europe: Shows significant growth with increasing research in personalized medicine and biotechnology.

Asia Pacific: Expected to witness rapid growth due to increased investments in healthcare, biotechnology, and drug development.

Rest of the World: Other regions, including Latin America and the Middle East, are also emerging as key markets due to increased awareness and healthcare advancements.

Regional Analysis

The peptide microarray market is geographically segmented into North America, Europe, Asia Pacific, and the rest of the world. North America holds a substantial market share, driven by the region’s advanced healthcare infrastructure, rising healthcare expenditures, and prominent biotechnology and pharmaceutical companies. Europe follows closely, with substantial research efforts in personalized medicine and drug development. The Asia Pacific region is anticipated to grow rapidly in the coming years, fueled by increasing investments in biotechnology, healthcare advancements, and expanding pharmaceutical industries.

Key Players

The major players are PEPperPRINT GmbH, RayBiotech Life, Inc., Creative Biolabs, Aurora Instruments Ltd., Kinexus Bioinformatics Corp., Pfizer Inc., Microarrays Inc., Bio-Rad Laboratories, JPT Peptide Technologies, Merck KGaA, Innopsys, and Others.

Key Points

Increasing demand for personalized medicine is a key driver of the market.

The peptide microarray market is growing due to the rising applications in drug discovery, diagnostics, and R&D.

North America is the dominant region, with Europe and Asia Pacific showing strong growth potential.

The market is being driven by advances in biotechnology, drug development, and precision medicine.

Technological advancements in microarray technology are enhancing the efficiency and capabilities of peptide microarrays.

Future Scope

The peptide microarray market is poised for continued expansion, with several future opportunities on the horizon. Innovations in peptide synthesis, increased integration with AI and machine learning for data analysis, and a greater emphasis on personalized medicine are expected to drive market growth. The demand for more accurate, high-throughput, and cost-effective diagnostic tools is also expected to create new avenues for growth. As the biotechnology and pharmaceutical sectors advance, the use of peptide microarrays in clinical settings will likely increase, leading to more widespread adoption and a broader application base in disease research, diagnostics, and therapeutic development.

Conclusion

In conclusion, the peptide microarray market is experiencing robust growth, driven by technological advancements and the increasing adoption of personalized medicine. Key sectors such as drug discovery, diagnostics, and R&D are benefiting from the capabilities of peptide microarrays. With continued innovation and increasing applications across various industries, the market is set to grow at a substantial pace in the coming years. As research and development continue to evolve, peptide microarrays will play a vital role in advancing scientific knowledge and improving healthcare outcomes.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Cell Viability Assay Market

Medical Power Supply Market

Post Traumatic Stress Disorder Treatment Market

MRI Guided Neurosurgical Ablation Market

[bhavesh2022]

North America Sepsis Diagnostics Market Growth Analysis, Key Players

Business Market Insights recently announced the release of the market research titled North America Sepsis Diagnostics Market Outlook to 2028 | Share, Size, and Growth. The report is a stop solution for companies operating in the North America Sepsis Diagnostics market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. North America Sepsis Diagnostics Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, Business Market Insights is helping brands unlock revenue opportunities in the North America Sepsis Diagnostics market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated North America Sepsis Diagnostics market research has all that you need.

What are Key Offerings Under this North America Sepsis Diagnostics Market Research?

Global North America Sepsis Diagnostics market summary, current and future North America Sepsis Diagnostics market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global North America Sepsis Diagnostics Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the North America Sepsis Diagnostics Market?

North America Sepsis Diagnostics market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. North America Sepsis Diagnostics market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their North America Sepsis Diagnostics market share.

Report Attributes

Details

Segmental Coverage

Product

Instruments

Reagents and Assays

Blood Culture Media

and Software

Technology

Molecular Diagnostics (Polymerase Chain Reaction

Peptide Nucleic Acid-Fluorescent in Situ Hybridization

Syndromic Panel-Based Testing

and Microarrays)

Flow Cytometry

Microfluidics

Immunoassay

B

Method

Automated Diagnostics and Conventional Diagnostics

Test Type

Point-of-Care Tests and Laboratory Tests

End User

Bacterial Sepsis

Fungal Sepsis

and Others

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Abbott

BD

bioMerieux SA

Danaher (Beckman Coulter)

F. HOFFMANN-LA ROCHE LTD.

Immunexpress Inc.

Luminex Corporation

T2 Biosystems, Inc.

THERMO FISHER SCIENTIFIC INC.

Other key companies 

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective North America Sepsis Diagnostics market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The Business Market Insights offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The North America Sepsis Diagnostics market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

[poonamcmi]

Peptide Synthesis Market to Grow Substantially owing to Wide Applications in Pharmaceutical Sector

The peptide synthesis market has gained major traction in recent years due to the wide applications of peptides in pharmaceutical development and research. Peptides are short chains of amino acids that can regulate numerous biological processes in humans. The peptide synthesis process involves the step-by-step fabrication of custom peptides as per research needs through chemical or enzymatic reactions. Peptides find applications as therapeutic drugs, diagnostics, vaccine development, and other biomedical applications. Technological advancements in peptide synthesis equipment and growing outsourcing of peptide production work to specialized contract manufacturing organizations are supporting the growth of the peptide synthesis industry.

The Global peptide synthesis market is estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the peptide synthesis market are GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth. These players are focusing on capacity expansion and new product launches to strengthen their market presence.

There is a huge opportunity for developing novel peptide-based drugs for the treatment of chronic diseases like cancer, diabetes, and cardiovascular diseases. Many biopharma companies are actively investing Peptide Synthesis Market Trends  discovery and development. Growing outsourcing of custom peptide synthesis jobs to contract manufacturing organizations is opening new revenue streams for market players.

The global expansion of major peptide synthesis companies through partnerships, acquisitions, and direct investments in emerging markets will help penetrate untapped opportunities. Asia Pacific and Middle East regions are witnessing major investments by key players to manufacture peptides for clinical research and commercial applications.

Market drivers

The major market driver is the wide applications of peptides in the pharmaceutical industry for developing novel drugs and diagnostics. Peptides have certain advantages over small molecule drugs such as high selectivity and potency. Moreover, the increasing incidence of chronic diseases worldwide is propelling pharmaceutical and biotech companies to focus on peptide-based therapeutics development. Growing R&D expenditure on proteomics and genomic research involving peptide synthesis techniques is another key factor supporting the market growth.

PEST Analysis

Political: The regulation policies of government regarding R&D activities and funding are expected to have a positive impact on the Peptide Synthesis Market Size And Trends Various government initiatives are promoting the growth of pharmaceutical and biotechnology sectors.

Economic: The increasing healthcare expenditure globally and availability of funding for research activities are the major macroeconomic factors augmenting the market growth. The rising disposable income is also driving the demand for advanced treatment options.

Social: Growing awareness about healthcare and rising prevalence of chronic diseases such as cancer, metabolic disorders are fueling the demand for peptide drugs and therapeutics. Advancements in proteomics and genomics are further supporting research activities in this field.

Technological: Adoption of innovative techniques like microarray peptide synthesis and high throughput peptide synthesis is accelerating the research process. Automation and use of robotics in synthesis is improving productivity and minimizing production costs.

The peptide synthesis market in terms of value is concentrated majorly in North America and Europe. North America alone holds around 40% of the global market share due to presence of advanced research infrastructure and major players in the US and Canada.

The Asia Pacific region is considered as the fastest growing market for peptide synthesis.This is attributed to increasing investments by market players, rapid economic development, growing biologics industry and rising focus on healthcare by governments in emerging countries like India and China. The governments are focusing on developing local manufacturing capabilities to reduce dependency on other regions. Get More Insights On, Peptide Synthesis Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[healthcare-market]

Peptide Array Services Market to Receive Overwhelming Hike in Revenues by 2024

Global Peptide Array Services Market: Overview

Peptide arrays are formed when a large number of peptides are arranged spatially in an addressable format and with the help of a solid support. This format of array comes with the benefit of enabling several experiments to be done on one single sample. Peptide array is one large pool of peptides to facilitate cost-effective synthesis that are similar in nature. The cost-effective of the product is likely to support growth of the global peptide array services market in the years to come. Powerful tools are needed for peptide array services and these tools need to give clinical details about drug-protein interaction and protein-protein relation. Technology has various services to cater to the need of various applications, which are modified according to the interest of the protein.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78359

It has resulted in various existing methods like custom peptide microarray and peptide library to be utilized for high end screening. These differences enabled a clear solution for a very different set of indications. Companies provide cost effective and quick peptide array services for the people. The more precise the service is, the more accurate the outcome and customer inclination are. Some of the peptide array services are dynamic in nature and can be utilized with an array of tube sections. The product is coming up with certain modifications with the safety and size in mind. Such multiple benefits are likely to support growth of the global peptide array services market in the years to come.

Type, end user, and region are the three important parameters based on which the global peptide array services market has been classified. The thorough analysis of the market is made with the sole purpose of providing the stakeholders with a detailed and clear analysis of the global peptide array services market.

Request a Sample of Peptide Array Services Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78359

Global Peptide Array Services Market: Notable Developments

An important market development offering a quick view of the dynamics related to the global peptide array services market is mentioned as below:

· In December 2019, US–based New England Peptide, Inc merged with Peptides International. With this merger, the latter is expected to make an addition of custom synthesis and catalog services to the custom design services of New England Peptide. It will also add manufacturing services for antibody and pharmaceutical peptide products of the New England Peptide.

Request for Analysis of COVID19 Impact on Peptide Array Services Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78359

Increased Demand from laboratories for Clinical Tests to Fuel Market Growth

The growth of the global peptide array services market is likely to be influenced by the availability of better quality products and expansion in usage. With the changing trends in the healthcare system, peptide array services are primarily used by laboratories to conduct their respective clinical tests over the specified period of time. Depending on the objective of the screening, different formats of array are produced. The growth of the global peptide array services market is likely to be driven by the augmented interest of the research sector in this product. The interaction between drug and peptide is investigated by researchers in most of the cases, which is likely to drive the demand of peptide array services over the period of assessment, 2020 to 2030.

In addition, several technological inventions, such as reagent and peptide printer are likely to encourage growth of the global peptide array services market over the period of assessment.

Pre-Book Peptide Array Services Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=78359&ltype=S

Global Peptide Array Services Market: Geographical Analysis

In the global peptide array services market, North America is estimated to remain at the forefront of the market growth. Growth of the region is ascribed to the presence of several regional manufacturers. Presence of advanced healthcare infrastructure and increased funding on research and development works are expected to pave way for rapid growth of the market in the region.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/technological-advancements-and-innovations-to-fuel-growth-of-soft-tissue-repair-market-from-2018-to-2026-tmr-301168624.html

https://www.prnewswire.com/news-releases/global-oral-contraceptive-pills-market-projected-to-expand-at-6-cagr-rising-number-of-unplanned-pregnancies-drives-market-demand-tmr-301171827.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of analysts, researchers, and consultants, who use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods, and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/

[sapanas]

Microarray Analysis Market Research Report - 2020 | Global Industry Size, Share, Growth, Analysis Forecast To 2023

“The Latest Research Report Global Microarray Analysis Market By 2023 provides information on Market Size, Analysis, Shares, Forecast, Emerging Technologies and Company Profiles for key Industry Participants – Market Research future”

Microarray Analysis Market Overview:

global microarray analysis market is expected to grow at a CAGR 9.8% during the forecast period 2017-2023.

A microarray can be defined as a multiplex lab-on-a-chip that has a two-dimensional array on a solid substrate to perform tests for various end users. It enables researchers to investigate and address subjects that were often counted as non-traceable. The process allows quick analysis of an expression of many genes quickly but with great efficiency. The process involves the hybridization of an mRNA molecule and the DNA template from which the mRNA has been collected. Collection of multiple samples form an array.

Read more news on: https://www.medgadget.com/2019/01/microarray-analysis-market-set-for-big-growth-by-qiagen-agilent-technologies-bio-rad-laboratories-illumina-inc-etc-market-research-future.html

Such extensive researches are now providing substantial traction to the pharmaceutical sector. Also, genetic testing can gain sufficiently from the microarray testing segment. These procedures would further gain momentum due to hike in healthcare expenditure. Owing to these features, the microarray analysis market growth can expect hike in valuation in the coming years.

Microarray Analysis Market Segmentation:

The study on the global market for microarray analysis can be formed by including segments like application, type, product type, and end-user. These segments are carriers of various factors that can be explored in the coming day for better understanding of the global market.

By type, microarray analysis market report can be segmented into chemical compound microarrays, tissue microarrays, glycan arrays, protein microarrays, phenotype microarrays, DNA microarrays, and cellular microarrays. The segment for DNA microarrays has the largest market share as its extensive use in diverse applications like pharmaceuticals, hospitals & clinics, diagnostic centers, ambulatory care centers, academic & research institutes, and biotechnology can impact the market notably.

By application, microarray analysis market share integrated drug discovery, disease diagnosis, research, genotyping, genomics, forensic analysis, proteomics, and toxicological research. The drug discovery segment has the better opportunity to score the highest CAGR during the review period due to growing need for personalized drug.

By product type, microarray analysis market includes reagent kits, reagents, DNA chips, instruments, primers, and buffers. The instrument segment covers Multi-Channel (MC) instrument, hybridization oven, centrifuge, scanner, target preparation instrument, slide imprinters, and others.

By end-users, microarray analysis market comprises academic & research institutes, pharmaceuticals, diagnostic centers, hospitals & clinics, biotechnology, ambulatory care centers, and others.

Microarray Analysis Market Regional Analysis:

Region-specific study of the market for microarray analysis spans across namely, Europe, the America, and Asia Pacific (APAC) where revenue generation would be pretty high and the Middle East and Africa (MEA) where the market would be restricted due to the presence of poor countries.

The American region has the better opportunity to dominate the market with the infrastructural benefits and high growth of the investment possibilities. Also, the presence of major market players is expected to provide traction to the market.

Europe’s growing focus on the research and development segment to boost the healthcare sector with drug discovery, personalized medicine, and targeted therapy would provide the market traction.

The Asia Pacific market has the potential to score big due to the hike in the prevalence of government initiatives, genetic disorders, and increasing awareness among the people.

Microarray Analysis Market Competitive Landscape:

Various companies are getting involved in taking the global microarray industry ahead by contributing substantially both in terms of money and strategic moves. These companies are NextGen Sciences PLC, Discerna, Thermo Fisher Scientific, Illumnia Inc., Roche NimbleGen, ProteoGenix, Luminex Corporation, Agilent Technologies Inc., Applied Microarrays, Biomerieux SA, Sequenom Inc., Gyros AB, Affymetrix Inc., and others. MRFR listed these companies for a better understanding of various trends that can impact the market in the coming years. The work is backed by the recording of latest contributions made by these companies.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/global-microarray-analysis-market-777

In August 2019, in the Annual Peptide Drug Design and Delivery Summit, researchers announced the possibility of nanotechnology is growing rapidly in the healthcare industry. Among sectors, in which it can be used, microarray tests are expected to show some strong potential. These particles are more suitable to allow free movement in various parts of the body in comparison with traditional therapeutic molecules.

[market-research-future]

North America Microarray Market SWOT Analysis, Growth and Future Outlook | Forecast to 2027

Market Highlights

The North America microarray market has been evaluated as slowly growing market and expected to continue in the similar way in the near future.  A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development. Microarray is one of the methods which was used for the diagnostic purpose in cancer research. But commonly used types like DNA microarray, antibody array have not been proven to be effective methods in case of the disease like cancer. So in order to deal with the limitations of other types, tissue microarray was developed. Tissue microarray is an effective diagnostic tool for cancer diagnosis. The more and more research is going on to make the tissue microarray more accurate and efficient. As the prevalence of cancer is spreading, the growth in the tissue microarray method is expected in the future.

On the other hand, as the technique is in its infancy stage, lots of mistakes and errors occur. The readings are not accurate many times. As the results are not reliable, it creates a hindrance in the growth of the tissue microarray method. Besides this, tissue microarrays are not recommended for certain types of studies. In certain tumors such as glioblastoma, there is such marked heterogeneity within tumors that this feature may not be adequately captured in tissue microarray studies. In addition, microarrays are also not very useful to study rare or focal events, such as number of immune cells in tumors. These are some of the factors that cause hindrance to the growth of the Tissue microarray market.

Taste the market data and market information presented through more than 16 market data tables and figures spread over 31 numbers of pages of the project report. Avail the in-depth TOC & market synopsis on “North America Microarray Market Research Report – Forecast to 2027.

Access Report Details @ https://www.marketresearchfuture.com/reports/north-america-microarray-market-2641

North America Microarray Market Players:

The major participants of this market are ABCAM, Asterand Bioscience, IHC World LLC, Novus Biologicals LLC (Acquired By BIO-TECHNE), Origene Technologies Inc, Pantomics, Inc, Protein Biotechnologies Inc, US Biomax, Inc., US Bioupton Int, Vitrovivo Biotech, LLC And Others

Regional Analysis:

North America tissue microarray market is segmented into two countries: United States, and Canada. U.S. is the largest market for tissue microarray. The U.S market for tissue microarray is expected to reach at USD 364.2 million by the end of the forecasted period. Canada is the second-largest market for tissue microarray which is expected to grow at a CAGR of 4.4%.

Segmentation:

North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray. On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others. On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.

Browse More Reports at:

Veterinary Pain Management Market Research, Size, Share, Trends, Global Analysis, 2027

Cell Cycle Analysis Market Overview, Size, Growth, Industry Forecast to 2027

Prescribed Health apps Market Growth By Devices, Size and Trend Forecast To 2024

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

[decisionforsight]

Global Biologics Market

Global Biologics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Biologics are pharmaceutical products derived from living cells or micro-organisms. These are complex and large molecules comprising of proteins, peptides, nucleic acids, sugars, cellular structures or a combination of all the above. The biologics drug discovery process involves target identification, hit-to-lead stage, lead identification & optimization. Technologies applied for the development of biologics include genomics, proteomics, microarrays, cell cultures, phage display technologies and monoclonal antibody technologies. Biologics include genes that control production of vital proteins; proteins that control the action of other proteins and cellular processes; and modify human hormones or cells that produce products that suppress or activate the components of the immune system. They are used for the treatment of various diseases such as rheumatoid arthritis, ulcerative colitis, and other autoimmune diseases. The common side effects of biologics drugs observed are weakness, chills, allergic reactions, nausea, diarrhoea, itching, vomiting, injection side reaction, constipation, cough, headache, fever, shortness of breath, fever, dizziness, and others. The major biologics drugs presently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin. The global biologics market is projected to reach USD 559.6 billion by 2030 from USD 274.1 billion in 2020, at an approximate CAGR of 7.40%.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020111

Market Dynamics and Factors:

Rising prevalence of chronic diseases, incessant research and development activities, and continuous investment in biologics are the major factors attributing to the market growth of the biologics market across the globe. For instance, according to the World Health Organization (WHO), by 2020 chronic diseases would constitute around 75% of the total deaths worldwide.  Cancer, autoimmune diseases, and diabetes attribute to almost 60% of the overall biologics market. In 2016, approximately 50% of the new molecular units approved by the Food and Drug Administration were biologics. Continuous advancements in cellular & gene therapy further catalyses the market because of its high efficacy and therapeutic outcome. Furthermore, other major factors such as rising expenditure on healthcare, increased availability of advanced diagnostics, and growing applications of monoclonal antibodies for the treatment of different diseases are also positively impacting the overall growth of the global biologics market. However, certain factors like the emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges are restraining the market growth of the global biologics market

Market Segmentation :

Global Biologics Market – By Source

Microbial

Mammalian

Others

Global Biologics Market – By Product Type

Monoclonal Antibody

Interleukins

Vaccines

Growth Factors

Gene Therapy

Others

Global Biologics Market – By Disease Indication

Immunological Disorders

Cardiovascular Disorders

Hematological Disorders

Cancer

Arthritis

Diabetes

Others

Global Biologics Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020111

Geographic Analysis:

North America is expected to dominate the global biologics market in terms of market share during the forecast period. The presence of key market players, continuous R&D in the biologics field, growing prevalence of chronic disorders, and longer patent protection compared to other regions are the major factors attributing to the market dominance of the region. For instance, U.S. pharmaceutical companies’ account for almost 80% of the world’s R&D in health care biotechnology. The Asia Pacific region is anticipated to witness the fastest growth in the biologics market during the forecast period. Expansion of international players in developing nations contribute to the biologics market growth in the APAC region. For instance, Novartis AG wishes to launch its FDA approved treatment Kymriah in Japan. Additionally, there has been a spurt of heavy investments by Asian contract manufacturers in order to grab share in the global biologics market. Companies such as Samsung Biologics and Wuxi Biologics are anticipated to drive the market growth in the Asian region.     

Competitive Scenario :

The key players operating in the global biologics market are –

AbbVie Inc., Amgen Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Bayer AG, Sanofi, Hoffman La-Roche, Samsung Biologics, Eli Lilly & Company, Merck & Co., Johnson & Johnson Services Inc.   

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020111

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Biologics industry, although key threats, opportunities and disruptive technologies that could shape the Global Biologics Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Biologics Market most.

The data analysis present in the Global Biologics Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Biologics Market business.

The 2021 Annual Global Biologics Market offers:

100+ charts exploring and analysing the Global Biologics Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biologics Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020111

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[bhagyashribhole123]

Genotyping Market 2019 Size, Trends, Industry Analysis, Leading Players & Future Forecast by 2023

Genotyping Market Analysis

Genotyping helps users in understanding a living organism’s genetic structure such as humans, animals, plants and microorganisms. It is basically an organism’s genetic mapping that includes both DNA sequencing as well as sequenced DNA’s analysis. Genotyping has various uses in medicine, agriculture and basic scientific research. The Global Genotyping Market Size is projected to have a healthy growth at an exponential 22.5% CAGR during the forecast period (2018-2023).

There are several factors that are driving the growth of the genotyping market. These factors according to the MRFR report include advancements in technology, rising prevalence of target diseases namely Alzheimer’s, diabetes and cancer, introduction of new technologies which reduce errors and offer effective results, increasing R&D activities in healthcare, rise in genetic ailments, surge in need for personalized medication and decrease in genotyping service price. On the contrary, factors such as dearth of skilled professionals and unfavorable reimbursement policies may hamper the growth of the genotyping market.

Key Players

Leading players profiled in the genotyping market include Thermo Fisher Scientific Inc. (USA), Sequenom (USA), Qiagen (Germany), Illumina Inc. (USA), General Electric Company (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Fluidigm Corporation (USA), Beckman Coulter Inc. (USA), Agilent Technologies Inc. (USA), and Affymetrix Inc. (USA).

Feb 2019 - Huasin and Genomica have entered into an agreement through which HuaSin availed exclusive rights for developing and producing HPV genotyping assay platform that is fully automated and uses Genomica’s technology. This genotyping technology will aid in detecting HPV in women prior to the development and spreading of cancer and expects it to also support vaccination programs that are long-needed and evolving.

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the genotyping market on the basis of product, end-user, application and technology.

Based on product, it is segmented into services, reagents and kits and instruments. Of these, reagents and kits will have the largest share in the market.

Based on end-user, the genotyping market is segmented into R&D centers, hospitals, diagnostic centers and academic institutes.

Based on application, it is segmented into personalized medicine, drug discovery and development, agriculture diagnostics and academic research. Of these, personalized medicine will lead the market and is expected to have the fastest growth.

Based on technology, the genotyping market is segmented into polymerase chain reaction (PCR), sequencing, microarray, mass spectrometry and capillary electrophoresis. Capillary electrophoresis is further segmented into single-strand conformation polymorphism (SSCP), restriction fragment length polymorphism (RFLP) and amplified fragment length polymorphism (AFLP). Microarrays is further segmented into peptide microarrays, MMChips, DNA microarrays and antibody microarrays. Sequencing is further segmented into sanger sequencing, pyrosequencing and next-generation sequencing. Of these, sequencing will lead the market during the forecast period.

Browse More Information:- https://www.marketresearchfuture.com/reports/genotyping-market-6635

Regional Analysis

Based on region, the genotyping market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will garner highest share in the market. Owing to technology, North America will have a higher share over South America. The factors that can be attributed for the growth of the market in North America include presence of several key players, accessibility of advanced and innovative medical facilities, rising incidences of genetic disorders, and support from the government for research and development. The USA and Canada are the leading contributors in North America while in South America, Brazil and Argentina will be the key contributors. Europe will have the second largest share in the genotyping market owing to the region’s well-established healthcare sector. The market here is having a favorable growth owing to accessibility of latest and advanced medical facilities, increasing investment in research and development by pharmaceutical companies, presence of leading market players and various governments investing in research and development. Western Europe will have a bigger share than Eastern Europe. The genotyping market in the APAC region is projected to grow at the fastest pace owing to rising disposable income, increasing investment by key market players, stable healthcare sector which is growing gradually and supportive government policies. Here the key contributors are India, Japan, China, Australia and South Korea. On the other hand, the genotyping market in Middle East and Africa will have minimal share owing to most governments not giving priority to healthcare, dearth of healthcare facilities, lack of education, medical facilities having low standard, lack of advanced and innovative medical facilities, lack of awareness and presence of poor countries.

[rishabh3210blog]

Global microarray market trends, growth, industry research & analysis report by type (DNA, protein, peptide, tissue & cellular microarray) by application (drug discovery, diagnosis and prognosis, pharmacogenomics and theragnostic) forecast 2018-23

[apurvafmi-blog]

Peptide array is simply a larger pool of peptides so that similar synthesis becomes a total cost-effective strategy.  Peptide Array Services require powerful tools that provide clinical details about protein-protein relation and drug-protein interaction. Technology has allowed services to meet applications that are customized as per the interest of protein. It has led to conventional methods like peptide library and custom peptide microarray for high-end screening. These differences made it possible for a clear solution for a different set of indications. Companies offer quick and cost-efficient peptide array services for the general public, and more precise the service is better the results and customer inclination. Some of the Peptide Array Services are versatile in nature and can be used with a range of tube sections. Peptide Array Services are coming up with specific adjustments, keeping the size and safety in mind.

The global Peptide Array Services market is estimated to see quality growth in the near future due to expansion in usage and quality products. An encouraging sign can be observed in the market with changing healthcare trends. Peptide Array Services are mostly consumed by laboratories to perform their respective clinical tests over the period. Dependent on the purpose of the screening, different types of array formats can be produced. The entire peptide array services market experiences attraction from the research sector, where drug-peptide interaction is investigated for most of the part. Different novel ranges in peptide array services type, and rise in reported cases coming to the facilities for treatment supports the growth of the peptide array services market. Parallel technological advances like peptide array printer and reagents support the peptide array services market. Peptide Array Services market faces hard reality in many undeveloped and low economy countries where the cost of peptide array services differs from most developed part of the world, which has an effect on the entire peptide array services market. The disadvantage following peptide array services includes traditional use of small chips to screen peptides, which in recent times got a replacement. Cellulose membranes are mostly used these days in peptide array services as they are hydrophilic, porous, and flexible inorganic as well as aqueous solvents.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/26209

The global market for peptide array services is segmented on basis of and geography:

Peptide Array Services Segment by Service Type

Random Peptide Library Screening

Combinatorial Peptide Library Screening

Cluster Peptide Library Screening

Customized Peptide Library

Loop Scan

Substitution Analysis

Truncation Analysis

Epitope Mapping

Peptide Array Services Segment by End User

Clinical Research Laboratory

Diagnostic Laboratory

The global peptide array services market is segmented by service type, end user and geography. Based on service type, the peptide array services market is driven by epitope mapping which is binding areas of a set of overlapping peptides from any protein sequence. Mostly peptide array services are used in diagnostic laboratories to diagnose the protein relation in a sample.

On the basis of regional presence, global peptide array services market is segmented into six key regions viz.  North America, Latin America, Europe, Asia-Pacific Excluding China, China, and the Middle East & Africa. North America leads the peptide array services market and reasons being fragmented regional manufacturer’s presence in the region, where manufacturers are targeting methods that involve lab testing through peptide array services in the region. Europe is the second leading market for peptide array services due to their healthcare infrastructure supporting the need of such technique and the presence of developed countries in the region. Supporting factors such as local awareness, disease prevalence, and economic shift are likely to drive the market growth of peptide array services during the forecast period globally. Adoption of new methods and technology assessment plays a vital role in the growth of peptide array services market.

Request Report TOC@ https://www.persistencemarketresearch.com/methodology/26209

Some of the major players in Peptide Array Services market are Agentide Inc., New England Peptide, Inc., Kinexus Bioinformatics Corporation, ProteoGenix, Innovagen AB, peptides & elephants, AS ONE INTERNATIONAL, LC Sciences, LLC, JPT Innovative Peptide Solutions and many more.

[sapanas]

Covid 19 Impact on Genotyping Market Growth Prospects, Key Opportunities, Trends, Forecasts, Key Company Profiles And Industry Size, Share Analysis

Genotyping Market Analysis

The global genotyping market is projected to have a healthy growth at an exponential 22.5% CAGR during the forecast period (2018-2023). Genotyping helps users in understanding a living organism’s genetic structure such as humans, animals, plants and microorganisms. It is basically an organism’s genetic mapping that includes both DNA sequencing as well as sequenced DNA’s analysis. Genotyping has various uses in medicine, agriculture and basic scientific research.

There are several factors that are driving the growth of the genotyping market. These factors according to the MRFR report include advancements in technology, rising prevalence of target diseases namely Alzheimer’s, diabetes and cancer, introduction of new technologies which reduce errors and offer effective results, increasing R&D activities in healthcare, rise in genetic ailments, surge in need for personalized medication and decrease in genotyping service price. On the contrary, factors such as dearth of skilled professionals and unfavorable reimbursement policies may hamper the growth of the genotyping market.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6635

Genotyping Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the genotyping market on the basis of product, end-user, application and technology.

Based on product, it is segmented into services, reagents and kits and instruments. Of these, reagents and kits will have the largest share in the market.

Based on end-user, the genotyping market is segmented into R&D centers, hospitals, diagnostic centers and academic institutes.

Based on application, it is segmented into personalized medicine, drug discovery and development, agriculture diagnostics and academic research. Of these, personalized medicine will lead the market and is expected to have the fastest growth.

Based on technology, the genotyping market is segmented into polymerase chain reaction (PCR), sequencing, microarray, mass spectrometry and capillary electrophoresis. Capillary electrophoresis is further segmented into single-strand conformation polymorphism (SSCP), restriction fragment length polymorphism (RFLP) and amplified fragment length polymorphism (AFLP). Microarrays is further segmented into peptide microarrays, MMChips, DNA microarrays and antibody microarrays. Sequencing is further segmented into sanger sequencing, pyrosequencing and next-generation sequencing. Of these, sequencing will lead the market during the forecast period.

Genotyping Market Regional Analysis

Based on region, the genotyping market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will garner highest share in the market. Owing to technology, North America will have a higher share over South America. The factors that can be attributed for the growth of the market in North America include presence of several key players, accessibility of advanced and innovative medical facilities, rising incidences of genetic disorders, and support from the government for research and development. The USA and Canada are the leading contributors in North America while in South America, Brazil and Argentina will be the key contributors. Europe will have the second largest share in the genotyping market owing to the region’s well-established healthcare sector. The market here is having a favorable growth owing to accessibility of latest and advanced medical facilities, increasing investment in research and development by pharmaceutical companies, presence of leading market players and various governments investing in research and development. Western Europe will have a bigger share than Eastern Europe. The genotyping market in the APAC region is projected to grow at the fastest pace owing to rising disposable income, increasing investment by key market players, stable healthcare sector which is growing gradually and supportive government policies. Here the key contributors are India, Japan, China, Australia and South Korea. On the other hand, the genotyping market in Middle East and Africa will have minimal share owing to most governments not giving priority to healthcare, dearth of healthcare facilities, lack of education, medical facilities having low standard, lack of advanced and innovative medical facilities, lack of awareness and presence of poor countries.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/genotyping-market-6635

Genotyping Market Key Players

Leading players profiled in the genotyping market include Thermo Fisher Scientific Inc. (USA), Sequenom (USA), Qiagen (Germany), Illumina Inc. (USA), General Electric Company (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Fluidigm Corporation (USA), Beckman Coulter Inc. (USA), Agilent Technologies Inc. (USA), and Affymetrix Inc. (USA).

Feb 2019 - Huasin and Genomica have entered into an agreement through which HuaSin availed exclusive rights for developing and producing HPV genotyping assay platform that is fully automated and uses Genomica’s technology. This genotyping technology will aid in detecting HPV in women prior to the development and spreading of cancer and expects it to also support vaccination programs that are long-needed and evolving.

[strategyr-blog]

The Global Market for Biotechnology Instrumentation is Projected to Reach US$53.3 Billion by 2022

Expanding Biotech Research at the Back of Robust New Drug Development Activity to Drive the Biotechnology Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Biotechnology Instrumentation market. The global market for Biotechnology Instrumentation is projected to reach US$53.3 billion by 2022, driven by the robust R&D investments in new drug development, enhancements in performance of existing technology platforms, and conceptualization of new measurement and instrument configuration systems.

Biotechnology has evolved into a wide and diverse industry over the years having undergone a transition from mere application of cultured microorganisms and animal and plant breeding processes to an advanced industry involving the use of various scientific and engineering disciplines. Today, biotechnology has become an important part of virtually every sector of the economy including chemical, agrochemical, beverage, food processing, healthcare, forensics, agriculture environmental monitoring, and animal husbandry, among others. The pharmaceuticals industry is the principal force driving the biotechnology revolution, primarily due to constant exploration for new drugs. Biotechnology instruments and tools are used in universities and pharmaceutical company research labs for cellular and molecular examination. Analytical instruments such as centrifuges, DNA synthesizers, protein analyzers and bio robotics are used by research laboratories in universities, and biotechnology and pharmaceutical companies. Over the years use of bioinstrumentation techniques has become simple and more accessible.

Demand for faster and economical ways to produce drugs for the pharmaceutical industry, proteomics, genomics, functional genomics and combinatorial chemistry have led to the advancements of bioinstrumentation in recent years. In addition to the human genome project that created ripples in the areas of proteomics and genomics, the market is also driven by considerable enhancements in performance of prevailing technology platforms, and conceptualization of new measurement and instrument configuration systems. Continuous advancements promise growth opportunities in clinical diagnostics, life sciences research, and personalized medicine. The evolution of Next-Generation Sequencing (NGS) technology has resulted in development of advanced molecular tools to facilitate the profiling the transcriptome and aid in the detection and analysis of noncoding RNA to understand cancer biology and create new therapeutic targets for cancer. The industry is expected to gain from expanding research and breakthroughs in areas such as molecular biology, next generation sequencing, and bioinformatics to analyze and interpret information at molecular level.

As stated by the new market research report on Biotechnology Instrumentation, the United States represents the largest market worldwide. Asia-Pacific is forecast to record the fastest CAGR of 9.5% over the analysis period led by robust growth from the Chinese and Indian markets. Growing population, rising per capita income, increasing government spending and increasing focus on research and development activity are the major factors contributing to the growth in the region.

Major players in the market include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE HealthCare, Gilson Inc., Harvard Bioscience Inc., Hitachi High-Technologies Corp., Illumina Inc., Lonza Group AG, PerkinElmer Inc., Roche Diagnostics, Shimadzu Corp., Siemens Healthineers, Thermo Fisher Scientific Inc., and Waters Corp. among others.

The research report titled “Biotechnology Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in value terms for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil, Mexico and Rest of Latin America) and Rest of World. Product segments analyzed include DNA Sequencing Systems, DNA Synthesizers, Electrophoresis Systems, Immunoassay Systems, Laboratory Automation, Liquid Chromatography Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers.

  For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.          To connect with us, visit our LinkedIn page.

 Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved. 

[healthy-insights]

Intensifying Research in Drug Discovery to Increase Adoption of Genomics and Proteomics Technologies in Healthcare Facilities, reports TMR

The global genomics and proteomics reagent and analytical instruments market has seen the emergence of new regional players, many of whom have successfully expanded beyond their original markets, reports Transparency Market Research (TMR) in a new study. Due to the high level of competitive rivalry within the market, the companies operating in this field are impelled to adopt highly competitive pricing and marketing strategies. The top three market players accounted for approximately 52.4% in the global genomics and proteomics market in 2012. The leading market player is Agilent followed by Thermofisher, and Life Technologies.  

As the genomics and proteomics market is highly fragmented, the players in the market are focusing on intense pricing strategies such as heavy discounts. Due to low loyalty, companies venturing in the genomics and proteomics market have fewer prospects of long term business opportunities. This can be only secured by having long term association with clients and meeting their requirements, says TMR.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/proteomics-market.html

Drug Discovery and Disease Identification to Boost Demand for Genomics and Proteomics Technologies

With the increasing awareness regarding drug discovery and disease management, the demand for genomics and proteomics technologies is also rising. The growth in the genome working mechanism has influenced researchers to take up researches in the field of rare genetic and central nervous system disease. The escalating demand for genomics and proteomics from HIV, cancer, and diabetes diagnostics is also expected boost the growth of the market. The increasing need for personalized medicine and companion diagnostics is also one the significant factor aiding the growth of the genomics and proteomics market. The growing awareness about prenatal and presymptomatic testing is also one of the major drivers for the adoption of genomics and proteomics techniques.

The increasing investments by developing countries such as India, China, and Brazil in healthcare and medical research for drug discovery are also likely to drive the growth of the global genomics and proteomics technology market.

High Cost of Technology to Hamper Implementation of Genomics and Proteomics Technologies in Developing Countries

The initial set up cost of genomics and proteomics technology is extremely expensive, making it difficult for developing countries to set them up. The required capital investment for setting up a modern laboratory is certain to reach several hundred millions of dollars. High end technological systems comprising next-gen sequencers, and mass spectrometers are considered to be out of reach for facilities in developing countries. Thus, the high cost of technology and expensive initial investment is anticipated to hinder the demand for genomics and proteomics technology in developing countries.

Collaboration among Global and Regional Companies to Help in Business Expansion

According to a TMR analyst, “The collaboration of global and regional research facilities is likely to provide vendors of genomics and proteomics technologies with substantial growth prospects. As there are sufficient epidemiological samples available from developing countries for carrying out diagnostic models and further enhancing data sets for disease testing, the collaborations between research facilities will help in the creation of commercial solutions for diseases, thus enhancing market growth.”

With favorable factors in dominance, the global genomics and proteomics market is expected rise at 12.1% CAGR between 2013 and 2019. The global genomics and proteomics market was valued at US$36.76 bn in 2015 and is projected to reach US$52.35 bn by the end of 2019. North America is expected to maintain its lead in the global market in terms of innovation in genomics and proteomics technology.

The review has been based on the findings of a TMR report titled, “Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=983

The global genomics and proteomics market is segmented into the following categories:

Genomics and Proteomics Market, by Reagent and Research Kits

Sample Preparation Kits

Purification Kits

Electrophoresis Kits

BioChips and Microarrays

Prepackaged Sample Preparation Kits for PCR

Prepackaged Sample Preparation Kits for Chromatography

Prepackaged Sample Preparation Kits for Mass Spectrometry

Prepackaged Sample Preparation Kits for  Electrophoresis

Capillary Electrophoresis/li>

Gel Electrophoresis

DNA BioChips and Microarrays

Protein and Peptide BioChips and Microarrays

Genomics and Proteomics Market, by Analytical Instruments

Chromatography

Mass Spectrometry, by Analyzers

Thermal Cyclers

Next Generation Sequencing

Gas Chromatography

Liquid Chromatography

Tandem Mass Spectrometry

Time-Of-Flight Mass Spectrometry

Quadrupole Mass Spectrometry

Fourier Transform Mass Spectrometry

Others(Magnetic Sector, Orbitrap, Ion Trap)

Digital Thermal Cyclers

Conventional or Traditional Thermal Cyclers

Real-Time Thermal Cyclers

Genomics and Proteomics Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com

[sapanas]

Microarray Analysis Market Growth: 2020 Global Industry Analysis, Size Estimation, Top Company Share, Regional Statistics

Microarray Analysis Market Research Report, Size, Growth and Industry Trends, Analysis By Technology (DNA Microarray, PCR, NGS, SAGE, and Northern Blotting), By Consumables (DNA Chips, DNA Microarrays, Protein Microarrays, Cellular Microarrays, Chemical Compound Microarrays, Antibody Microarrays and others), By Services (Gene Profiling and Bioinformatics) and By Applications (Research, Drug Discovery and Diagnostic) - Global Forecast till 2023

Microarray Analysis Market Overview:

global microarray analysis market growth is expected to grow at a CAGR 9.8% during the forecast period 2017-2023.

A microarray can be defined as a multiplex lab-on-a-chip that has a two-dimensional array on a solid substrate to perform tests for various end users. It enables researchers to investigate and address subjects that were often counted as non-traceable. The process allows quick analysis of an expression of many genes quickly but with great efficiency. The process involves the hybridization of an mRNA molecule and the DNA template from which the mRNA has been collected. Collection of multiple samples form an array.

Such extensive researches are now providing substantial traction to the pharmaceutical sector. Also, genetic testing can gain sufficiently from the microarray testing segment. These procedures would further gain momentum due to hike in healthcare expenditure. Owing to these features, the microarray analysis market growth can expect hike in valuation in the coming years.

Microarray Analysis Market Segmentation:

The study on the global market for microarray analysis can be formed by including segments like application, type, product type, and end-user. These segments are carriers of various factors that can be explored in the coming day for better understanding of the global market.

By type, microarray analysis market report can be segmented into chemical compound microarrays, tissue microarrays, glycan arrays, protein microarrays, phenotype microarrays, DNA microarrays, and cellular microarrays. The segment for DNA microarrays has the largest market share as its extensive use in diverse applications like pharmaceuticals, hospitals & clinics, diagnostic centers, ambulatory care centers, academic & research institutes, and biotechnology can impact the market notably.

By application, microarray analysis market share integrated drug discovery, disease diagnosis, research, genotyping, genomics, forensic analysis, proteomics, and toxicological research. The drug discovery segment has the better opportunity to score the highest CAGR during the review period due to growing need for personalized drug.

By product type, microarray analysis market includes reagent kits, reagents, DNA chips, instruments, primers, and buffers. The instrument segment covers Multi-Channel (MC) instrument, hybridization oven, centrifuge, scanner, target preparation instrument, slide imprinters, and others.

By end-users, microarray analysis market comprises academic & research institutes, pharmaceuticals, diagnostic centers, hospitals & clinics, biotechnology, ambulatory care centers, and others.

Microarray Analysis Market Regional Analysis:

Region-specific study of the market for microarray analysis spans across namely, Europe, the America, and Asia Pacific (APAC) where revenue generation would be pretty high and the Middle East and Africa (MEA) where the market would be restricted due to the presence of poor countries.

The American region has the better opportunity to dominate the market with the infrastructural benefits and high growth of the investment possibilities. Also, the presence of major market players is expected to provide traction to the market.

Europe’s growing focus on the research and development segment to boost the healthcare sector with drug discovery, personalized medicine, and targeted therapy would provide the market traction.

The Asia Pacific market has the potential to score big due to the hike in the prevalence of government initiatives, genetic disorders, and increasing awareness among the people.

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/global-microarray-analysis-market-777

Microarray Analysis Market Competitive Landscape:

Various companies are getting involved in taking the global microarray industry ahead by contributing substantially both in terms of money and strategic moves. These companies are NextGen Sciences PLC, Discerna, Thermo Fisher Scientific, Illumnia Inc., Roche NimbleGen, ProteoGenix, Luminex Corporation, Agilent Technologies Inc., Applied Microarrays, Biomerieux SA, Sequenom Inc., Gyros AB, Affymetrix Inc., and others. MRFR listed these companies for a better understanding of various trends that can impact the market in the coming years. The work is backed by the recording of latest contributions made by these companies.

In August 2019, in the Annual Peptide Drug Design and Delivery Summit, researchers announced the possibility of nanotechnology is growing rapidly in the healthcare industry. Among sectors, in which it can be used, microarray tests are expected to show some strong potential. These particles are more suitable to allow free movement in various parts of the body in comparison with traditional therapeutic molecules.

Click here to read more reports on Life Science

[rishabh3210blog]

Microarray Market: Industry Size, Share, Growth and Forecast 2018-2023

Increasing focus on drug discovery is boosting the Global Microarray Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: Agilent Technologies, Inc., Applied Microarrays, Inc., GE Healthcare, PerkinElmer, Inc. and F. Hoffman-La Roche Ltd.

Orion Market Research (OMR) recently published a market research report on the global microarray market. According to OMR analysis, the global microarray market is estimated to grow at a significant CAGR during the forecast period (2018-2023). Rising focus on drug discovery and significant need for error-free molecular testing tools are some factors encouraging the growth of the global microarray market. Moreover, increasing prevalence of chronic diseases has been significantly increased the demand for an innovative molecular testing solution to perform the microbiology, cancer, and pharmacogenetic testing. Moreover, rising adoption of microarrays in bacterial pathogenesis research is also fueling the growth of the market.

A full report of the global microarray market is available at: https://www.omrglobal.com/industry-reports/microarray-market/

Furthermore, the global microarray market is segmented on the basis of type and application. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Visit here to know more about Global Microarray Market Size.

Market Segmentation

Global Microarrays Market by Type

DNA Microarrays

Protein Microarray

Peptide Microarray

Tissue Microarray

Cellular Microarray

Others

Global Microarrays Market by Application

Diagnosis and Prognosis

Pharmacogenomics and Theragnostic

Drug Discovery

Others

Region Covered

North America (the US and Canada)

Europe (United Kingdom, Germany, France, Spain, and Italy)

Asia-Pacific (China, India, South Korea, and Japan)

Company Profiled

Abcam PLC

Agilent Technologies, Inc.

Applied Microarrays, Inc.

Arrayit Corp.

Aurora Biomed, Inc.

Axela, Inc.

AXO Science SAS

AYOXXA Biosystems GmbH

bioMérieux SA

Bio-Rad Laboratories, Inc.

Request a free sample of our report on Microarray Market: https://www.omrglobal.com/request-sample/?id=18911

The key questions answered in the Microarray Market study:

To analyze the Microarray Market size (values and volume) by type, application with historical data of 2017 and 2018 and forecast to 2023.

To study the key factors influencing the growth of the market.

Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.

To analyze the Global Microarray Market Size, growth, global trends, future prospectus and contribution to the market.

For related reports

Endoscopy Devices Market

Global Injectable Drug Delivery Market

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Reports

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

[bhagyashribhole123]

Genotyping Market 2019 Global Overview, Regional Analysis, Size, Share and Forecast to 2023

Genotyping services help users to understand the genetic structure of any living organisms such as animals, humans, microorganisms, and plants.  

The major factors driving the global genotyping market growth include increasing research and development (R&D) activities in the healthcare sector and the rising prevalence of genetic ailments. Other factors contributing to the market growth include technological advancement, decreasing prices of genotyping services due to intense competition, and surge in demand for personalized medication. However, the lack of skilled professionals and uncertainty related to reimbursement may hinder the market growth.

The Global Genotyping Market accounted for USD 6120 million in 2015 and expected to register healthy growth during the forecast period (2018–2023) at a CAGR of 22.5%.

To Get Free Sample Copy visit https://www.marketresearchfuture.com/sample_request/6635

Key Players

Market Research Future (MRFR) recognizes the following companies as the key players in Genotyping Market: There are plenty of large and small market players which operate in this market all over the globe.

The key players in the global genotyping market include Affymetrix Inc. (USA), Agilent Technologies Inc. (USA), Beckman Coulter Inc. (USA), Fluidigm Corporation (USA), F. Hoffmann-La Roche Ltd. (Switzerland), General Electric Company (USA), Illumina Inc. (USA), Qiagen (Germany), Sequenom (USA), and Thermo Fisher Scientific Inc. (USA).

Latest Industry News

NRGene and Macrogen Corp are set to launch a joint sequencing-based genotyping service, ArrayMAGIC. 12 JAN 2019

In Cordova, robots and robotic body parts implanted into disabled humans are helping the scientific procedures. Robots have helped a genetic testing lab complete 20 millionth sample. 25 JAN 2019

Segments

The global genotyping market has been segmented on the basis of application, end user, product, technology, and lastly, region. The application-based segmentation has segmented this market into academic research, agriculture, diagnostics, drug discovery & development, and personalized medicine. Based on end users, this market has been segmented into academic institutes, diagnostic centers, hospitals, and R&D centers.

The product-based segmentation covers instruments, reagents & kits, and services. On the basis of technology, the market has been segmented into capillary electrophoresis, mass spectrometry, microarray, sequencing, and polymerase chain reaction (PCR). The capillary electrophoresis segment has been sub-segmented into amplified fragment length polymorphism (AFLP), restriction fragment length polymorphism (RFLP), and single-strand conformation polymorphism (SSCP). The microarrays segment has been sub-segmented into antibody microarrays, DNA microarrays, MMChips, and peptide microarrays. The sequencing segment has been sub-segmented into next-generation sequencing, pyrosequencing, and Sanger sequencing.

Regional Analysis

The regional segmentation of the global genotyping market has segmented the global market into regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas hold the largest market share of the global market as North America alone is capable of holding this share anyways. Due to technology, North America is a bigger market than South America. In North America, the market is growing due government support for R&D, increasing cases of genetic disorders, the availability of advanced medical facilities, and the presence of many key market players. In North America, the vital country-specific markets are USA and Canada. In South America, Argentina and Brazil are two strong economies that can be suitable markets in the future.

Europe is a major regional market due to the well-established healthcare sector. In this region, the market is growing due to various governments funding the R&D, presence of many key market players, rising investment into R&D by pharmaceutical companies, and the availability of advanced medical facilities that are second only to North America. In Europe, due to reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. The country-specific markets France, Germany, Italy, Spain, and the UK, followed by the remaining countries of Western Europe as well as Eastern Europe.

During the forecast period, the Asia Pacific region has been anticipated to rise as the fastest-growing regional market. In the Asia Pacific region, the market is growing due to increasing disposable income, rising investment by market players in this region, the presence of stable healthcare sector that is growing gradually, and lastly, supportive government policies. The key country-specific markets in this region are Australia, China, India, Japan, and South Korea, followed by the remaining countries of the Asia Pacific region.

The MEA region is the smallest regional market. In this region, the market is small and limited due to poor countries, lack of awareness, lack of advanced medical facilities, low standard of medical facilities, lack of education, lack of healthcare facilities, and most governments not considering healthcare a priority.

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

TOC Continued…

Browse Complete Report @ https://www.marketresearchfuture.com/reports/genotyping-market-6635

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com